Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Summary
This reports provides a data-driven overview of the current and future competitive landscape in CIDP therapeutics.
Synopsis
- In 2022, there will be more than 180,000 diagnosed prevalent cases of CIDP across 16 pharmaceutical markets.
- The majority of marketed drugs for the treatment of CIDP fall into the human immunoglobulins category.
- There are only six drugs in Phase III pipeline for CIDP.
- Commercial sponsors dominate clinical trial development in CIDP, with Europe emerging as the key region for conducting Phase III trials in CIDP.
- In deals involving companies developing CIDP assets, four strategic alliances were successfully completed.
- During the next 18 months, only one drug is expected to enter the US and the EU markets.
GlobalData’s Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include -
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Retail or Manufacturer Price of Products
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the CIDP market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global CIDP market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
- Report Scope
- Key Findings
- Disease Overview
- Epidemiology Overview
- Epidemiology Overview: Total Diagnosed Prevalent Cases of CIDP in 2022
- Treatment Overview
- Treatment Guidelines
- Marketed Drugs Assessment
- Marketed Drugs – Leading Marketed Drugs in CIDP
- Marketed Drugs – Overview by Mechanism of Action
- Marketed Drugs – Overview by Route of Administration
- Marketed Drugs – Overview by Molecule Type
- Marketed Drug Profile: Biotest AG’s Immune Globulin (Human)
- Marketed Drug Profile: Octapharma and Pfizer’s Immune Globulin (Human)
- Marketed Drug Profile: CSL’S Immune Globulin (Human)
- Marketed Drug Profile: Grifols’s Immune Globulin (Human)
- Pricing and Reimbursement Assessment
- Marketed Drugs – Manufacturer Price ($/mg)
- Pipeline Drugs Assessment
- Pipeline Drugs Overview – Phase III and II Pipeline Drugs in CIDP
- Pipeline Drugs – Overview by Development Stage
- Pipeline Drugs – Overview by Molecule Type
- Pipeline Drugs – Overview by Mechanism of Action
- Pipeline Drugs – Overview by Route of Administration
- Pipeline Drugs – Phase Transition Success Rate and Likelihood of Approval in Central Nervous System and in CIDP
- Pipeline Drugs – Drug-Specific Phase Transition Success Rate and Likelihood of Approval in CIDP
- Clinical Trials Assessment
- Clinical Trials in CIDP – Historical Overview
- Clinical Trials in CIDP – Overview by Phase
- Clinical Trials in CIDP – Overview by Status
- Clinical Trials in CIDP – Overview by Phase for Ongoing and Planned Trial
- Clinical Trials in CIDP – Trials with a Virtual Component
- Clinical Trials in CIDP – Geographic Overview
- Clinical Trials in CIDP – Single-Country and Multinational Trials by Region
- Clinical Trials in CIDP – Top 20 Sponsors with Breakdown by Phase
- Clinical Trials in CIDP – Top 20 Sponsors with Breakdown by Status
- Clinical Trials in CIDP – Overview by Endpoint Status
- Clinical Trials in CIDP – Overview by Race and Ethnicity
- Clinical Trials in CIDP – Enrollment Data
- Clinical Trials in CIDP – Overview of Sites by Geography
- Clinical Trials in CIDP – Top 20 Countries for Trial Sites
- Clinical Trials in CIDP– Top 20 Sites Globally
- Clinical Trials – Feasibility Analysis: Geography Overview
- Clinical Trials – Feasibility Analysis: Benchmark Models for CIDP
- Deals Landscape
- Deals Landscape – Mergers, Acquisitions, and Strategic Alliances in CIDP by Region
- Deals Landscape – Recent Mergers, Acquisitions, and Strategic Alliances in CIDP
- Commercial Assessment
- Commercial Assessment – Key Market Players in CIDP
- Future Market Catalysts
- Future Market Catalysts – Upcoming Market Catalysts in CIDP
- Appendix
- Methodology
- Methodology – Sales Forecasts
- Methodology – Pricing and Reimbursement
- Methodology – Phase Transition Success Rate and Likelihood of Approval Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook